Friday, August 29, 2014 Last update: 11:03 AM - All Company Technology News Since 1996

Transcept Pharmaceuticals, Inc.

News articles for Transcept Pharmaceuticals, Inc.:

Tuesday, July 1, 2014

  • Transcept Pharmaceuticals and Paratek Pharmaceuticals Sign Merger Agreement
    BOSTON, Mass., and POINT RICHMOND, Calif., July 1, 2014 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) and Paratek Pharmaceuticals, Inc., a privately-held biopharmaceutical company, announced today that they have entered into a definitive merger agreement under which the stockholders of Paratek will become the majority owners of Transcept and the ... read more

Wednesday, May 14, 2014

  • Transcept Declares Special Cash Dividend Of $25 Million
    POINT RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Transcept Pharmaceuticals Inc. (NASDAQ: TSPT) announced today that its board of directors declared a special cash dividend of $1.33 per share on the Company's common stock. Payment will be made on June 3, 2014, to stockholders of record at ... read more

Monday, May 5, 2014

  • Transcept Pharmaceuticals Reports First Quarter 2014 Financial Results
    POINT RICHMOND, Calif., May 5, 2014 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three months ended March 31, ... read more

Thursday, March 13, 2014